Cargando…
Biology of MiR-17-92 Cluster and Its Progress in Lung Cancer
MicroRNAs, a class of short endogenous RNAs, acting as post-transcriptional regulators of gene expression, mostly silence gene expression via binding imperfectly matched sequences in the 3'UTR of target mRNA. MiR-17-92, a highly conserved gene cluster, has 6 members including miR-17, miR-18a, m...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6216058/ https://www.ncbi.nlm.nih.gov/pubmed/30443163 http://dx.doi.org/10.7150/ijms.27341 |
_version_ | 1783368270870478848 |
---|---|
author | Zhang, Xinju Li, Yanli Qi, Pengfei Ma, Zhongliang |
author_facet | Zhang, Xinju Li, Yanli Qi, Pengfei Ma, Zhongliang |
author_sort | Zhang, Xinju |
collection | PubMed |
description | MicroRNAs, a class of short endogenous RNAs, acting as post-transcriptional regulators of gene expression, mostly silence gene expression via binding imperfectly matched sequences in the 3'UTR of target mRNA. MiR-17-92, a highly conserved gene cluster, has 6 members including miR-17, miR-18a, miR-19a, miR-20a, miR-19b-1 and miR-92a. The miR-17-92 cluster, regarded as oncogene, is overexpressed in human cancers. Lung cancer is the leading cause of death all over the world. The molecular mechanism of lung cancer has been partly known at the levels of genes and proteins in last decade. However, new prognosis biomarkers and more target drugs should be developed in future. Therefore, noncoding RNAs, especially miRNAs, make them as new potentially clinical biomarkers for diagnosis and prognosis. In this review, we focus the current progress of miR-17-92 cluster in lung cancer. |
format | Online Article Text |
id | pubmed-6216058 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Ivyspring International Publisher |
record_format | MEDLINE/PubMed |
spelling | pubmed-62160582018-11-15 Biology of MiR-17-92 Cluster and Its Progress in Lung Cancer Zhang, Xinju Li, Yanli Qi, Pengfei Ma, Zhongliang Int J Med Sci Review MicroRNAs, a class of short endogenous RNAs, acting as post-transcriptional regulators of gene expression, mostly silence gene expression via binding imperfectly matched sequences in the 3'UTR of target mRNA. MiR-17-92, a highly conserved gene cluster, has 6 members including miR-17, miR-18a, miR-19a, miR-20a, miR-19b-1 and miR-92a. The miR-17-92 cluster, regarded as oncogene, is overexpressed in human cancers. Lung cancer is the leading cause of death all over the world. The molecular mechanism of lung cancer has been partly known at the levels of genes and proteins in last decade. However, new prognosis biomarkers and more target drugs should be developed in future. Therefore, noncoding RNAs, especially miRNAs, make them as new potentially clinical biomarkers for diagnosis and prognosis. In this review, we focus the current progress of miR-17-92 cluster in lung cancer. Ivyspring International Publisher 2018-09-07 /pmc/articles/PMC6216058/ /pubmed/30443163 http://dx.doi.org/10.7150/ijms.27341 Text en © Ivyspring International Publisher This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions. |
spellingShingle | Review Zhang, Xinju Li, Yanli Qi, Pengfei Ma, Zhongliang Biology of MiR-17-92 Cluster and Its Progress in Lung Cancer |
title | Biology of MiR-17-92 Cluster and Its Progress in Lung Cancer |
title_full | Biology of MiR-17-92 Cluster and Its Progress in Lung Cancer |
title_fullStr | Biology of MiR-17-92 Cluster and Its Progress in Lung Cancer |
title_full_unstemmed | Biology of MiR-17-92 Cluster and Its Progress in Lung Cancer |
title_short | Biology of MiR-17-92 Cluster and Its Progress in Lung Cancer |
title_sort | biology of mir-17-92 cluster and its progress in lung cancer |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6216058/ https://www.ncbi.nlm.nih.gov/pubmed/30443163 http://dx.doi.org/10.7150/ijms.27341 |
work_keys_str_mv | AT zhangxinju biologyofmir1792clusteranditsprogressinlungcancer AT liyanli biologyofmir1792clusteranditsprogressinlungcancer AT qipengfei biologyofmir1792clusteranditsprogressinlungcancer AT mazhongliang biologyofmir1792clusteranditsprogressinlungcancer |